Don't Eat the Brown Acid: Induced ‘Malnovation’ in Drug Markets

36 Pages Posted: 10 Aug 2015 Last revised: 16 May 2016

Audrey Redford

Western Carolina University - College of Business

Date Written: August 1, 2015

Abstract

Title II, the Controlled Substances Act (CSA), of the Comprehensive Drug Abuse Prevention and Control Act of 1970 created the system of drug scheduling and regulation used to this day. This paper illustrates how the CSA created the incentives for induced ‘malnovation’ (innovation intended to circumvent legislation, and thus foil policymakers’ intended ends) into drug markets, namely “designer drugs.” As a result of this induced malnovation, drug markets have not only increased in variance of products available that are often sold under similar street names, but there is a tendency towards creating more dangerous drugs in an attempt to stay outside of the regulation.

Keywords: induced malnovation, Comprehensive Drug Abuse Prevention and Control Act of 1970, Controlled Substances Act, designer drugs

JEL Classification: K42, L51, O31

Suggested Citation

Redford, Audrey, Don't Eat the Brown Acid: Induced ‘Malnovation’ in Drug Markets (August 1, 2015). Review of Austrian Economics, Forthcoming. Available at SSRN: https://ssrn.com/abstract=2641731 or http://dx.doi.org/10.2139/ssrn.2641731

Audrey Redford (Contact Author)

Western Carolina University - College of Business ( email )

United States

Paper statistics

Downloads
104
Rank
211,156
Abstract Views
355